Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML

NCT01277484 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Acute Myeloid Leukemia

Interventions

DRUG: Decitabine

Sponsor

Seoul St. Mary's Hospital

Collaborators

[object Object]